Trial Profile
Telaprevir pharmacokinetics trial in patients undergoing treatment for HCV genotype 1 infection receiving telaprevir based triple therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary)
- Indications Hepatitis C
- Focus Pharmacokinetics
- 27 Dec 2015 New trial record